Short-term hemodynamic effect of a new oral PGI2 analogue, Beraprost, in primary and secondary pulmonary hypertension

We conclude that Beraprost appears to be an effective and possibly available substitute for intravenous vasodilators in the treatment of primary PH and secondary PH. This preliminary report may offer favorable hemodynamic effects of a new oral PGI2 analogue in patients with PH.